Register
Journal Updates
eMediNexus Coverage from: 
Immunotherapy-related pruritus among patients with cancer is common
eMediNexus,  01 January 2019
remove_red_eye 575 Views
#Allergy and Immunology #Dermatology #Oncology

0 Read Comments                

According to a new research published online Dec. 12, 2018 in JAMA Dermatology, pruritus is a common adverse event associated with the use of immunotherapies for the treatment of cancer and can significantly compromise quality of life and overall function.
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!